Home
Activity Overview
Related Articles
Tralokinumab and Acitretin in Lamellar Ichthyosis
This case report describes a man in his 30s who presented with severe and generalized congenital ichthyosis and was treated with a combination of tralokinumab…
Top 5 Articles of the Week: January 5-10
Explore the top headlines of the week including clinical trial updates, FDA announcements, and expert insights.
Home
With novel radiopharmaceutical therapies entering clinical trials and into clinical practice, the 2025 Transatlantic Exchange in Oncology will focus on bringing together key experts from…
The Weekly Roundup: January 5 – 11
In case you missed it, this week we had news about phase 2b enrollment for VYNE’s vitiligo gel, the impact of anti-inflammatory moisturizers for AD,…
ICYMI: Eirion ET-02’s Successful Phase 1 Trial Results for Androgenic Alopecia Treatment
The 5% dosage showed a 6-fold increase in non-vellus hair count after just 5 weeks.
Low-Dose Naltrexone Use in Biopsy-Proven Lichen Planus of the Nails
This case series examines the effectiveness of low-dose naltrexone in treating nail lichen planus.
DFD-29: The Journey to FDA Approval and a New Era in Rosacea Management
DFD-29, FDA-approved in 2024, revolutionizes rosacea management by addressing both erythema and inflammatory lesions with a novel extended-release formulation.
Fractional Radiofrequency Microneedling is a Safe Monotherapy for Acne Scarring
A recent systemic review found FRM to be an effective treatment modality on its own for managing facial acne scars.